文献速递心外重症与机械循环支持

心血管外科术后ECMO患者预后评分系统的判别效能

Discriminatory power of scoring systems for outcome prediction in patients with extracorporeal membrane oxygenation following cardiovascular surgery†.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

该单中心观察性注册研究纳入240例心血管外科术后接受静脉-动脉ECMO治疗的患者,分析EuroSCORE、SOFA、SAPS II、SAVE等多种评分系统对结局的预测能力。中位随访37个月期间65%患者死亡,仅SAVE评分和SAPS II与30天死亡率显著相关,C-index分别为0.61和0.57;两者也是长期死亡率的最强预测因子。结论认为基于现有风险模型对ECMO患者进行风险评估仍然困难。

要点

  • 心血管外科术后VA-ECMO患者中位随访37个月死亡率达65%。
  • 仅SAVE评分与SAPS II与30天死亡率显著相关,判别力中等。
  • SAVE评分与SAPS II也是长期死亡率的最强预测因子。

核心结论

  • 基于现有风险模型对ECMO患者进行风险评估仍然困难。
  • 仅SAPS II和SAVE评分适用于该特定脆弱人群的短期和长期结局预测。

研究设计与样本

  • 观察性单中心注册研究,纳入240例心血管外科术后接受静脉-动脉ECMO治疗的患者。
  • 分析EuroSCORE additive、EuroSCORE II、SOFA、SAPS II、SAPS III、APACHE II、RIFLE分类、SAVE评分、ENCOURAGE评分和STS风险模型的判别效能。

主要发现

  • 中位随访37个月(四分位距19-67),65%的患者死亡。
  • 仅SAVE评分和SAPS II与30天死亡率显著相关,SAVE评分HR 1.06(95%CI 1.02-1.11;P=0.002),SAPS II HR 1.02(95%CI 1.01-1.03;P=0.004),C-index分别为0.61和0.57。
  • 10个评分系统中有7个与长期死亡率显著相关,SAVE评分HR 1.06(95%CI 1.03-1.09;P<0.001,C-index 0.61),SAPS II HR 1.02(95%CI 1.01-1.03;P<0.001,C-index 0.58)。

临床怎么用

  • 在心血管外科术后VA-ECMO患者中,可考虑使用SAVE评分和SAPS II辅助短期与长期预后评估。
  • 其他常用评分系统在该人群中的判别效能有限,不宜单独依赖。

局限性

  • 单中心观察性注册研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Although extracorporeal membrane oxygenation (ECMO) represents a rapidly evolving treatment option in patients with refractory heart or lung failure, survival remains poor and appropriate risk stratification challenging because established risk prediction models have not been validated for this specific population. METHODS: This observational single-centre registry included a total of 240 patients treated with venoarterial ECMO therapy following cardiovascular surgery and analysed the discriminatory power of the European System of Cardiac Operative Risk Evaluation (EuroSCORE) additive, the EuroSCORE II, the Sequential Organ Failure Assessment (SOFA) score, the Simplified Acute Physiology Score (SAPS) II, the SAPS III, the Acute Physiology and Chronic Health Evaluation (APACHE) II, the Risk of renal failure, Injury to the kidney, Failure of kidney function, Loss of kidney function and End-stage renal failure (RIFLE) classification, the survival after venoarterial ECMO (SAVE) score, the prEdictioN of Cardiogenic shock OUtcome foR AMI patients salvaGed by VA-ECMO (ENCOURAGE) score and the Society of Thoracic Surgeons (STS) risk model for outcome prediction. RESULTS: During a median follow-up time of 37 months (interquartile range 19-67), 65% of the patients died. Only the SAVE score and the SAPS II were significantly associated with the 30-day mortality rate with a hazard ratio (HR) of 1.06 [95% confidence interval (CI) 1.02-1.11; P = 0.002] for the SAVE score and an HR of 1.02 (95% CI 1.01-1.03; P = 0.004) for the SAPS II with a modest discriminatory power displayed by a C-index of 0.61 and 0.57, respectively. Seven out of 10 scoring systems revealed significant association with long-term mortality, with the SAVE score and the SAPS II remaining the strongest predictors of long-term mortality with an HR of 1.06 (95% CI 1.03-1.09; P < 0.001, C-index 0.61) for the SAVE score and an HR of 1.02 (95% CI 1.01-1.03; P < 0.001, C-index 0.58) for the SAPS II. CONCLUSIONS: Risk assessment based on established risk models in patients with ECMO remains difficult. Only the SAPS II and the SAVE score were exclusively found to be suitable for short- and long-term outcome prediction in this specific vulnerable patient population.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Schrutka L, Rohmann F, Binder C, et al. Discriminatory power of scoring systems for outcome prediction in patients with extracorporeal membrane oxygenation following cardiovascular surgery†. Eur J Cardiothorac Surg. 2019. PMID: 30789227. doi:10.1093/ejcts/ezz040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。